Linda Marbán, Capricor CEO

Ex­clu­sive: Johns Hop­kins pro­fes­sor and biotech col­leagues tout new tech to test Covid-19 vac­cine re­sponse

Vari­ants to the SARS-CoV-2 virus have emerged of late as yet an­oth­er threat to a pan­dem­ic that’s al­ready killed over 2.2 mil­lion peo­ple world­wide.

The Covid-19 vac­cines al­ready on the mar­ket have so far man­aged to re­tain at least some lev­el of ef­fi­ca­cy in treat­ing new, more in­fec­tious strains of the res­pi­ra­to­ry virus — but con­cern about oth­er mu­ta­tions re­mains pal­pa­ble as a slow, churn­ing vac­cine roll­out con­tin­ues across the globe.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.